Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer... by Garassino, Marina C, MD, Gadgeel, Shirish, MBBS, Esteban, Emilio, MD, Felip, Enriqueta, PhD, Speranza, Giovanna, MD, Domine, Manuel, PhD, Hochmair, Maximilian J, PhD, Powell, Steven, MD, Cheng, Susanna Yee-Shan, MD, Bischoff, Helge G, MD, Peled, Nir, Prof, Reck, Martin, MD, Hui, Rina, PhD, Garon, Edward B, MD, Boyer, Michael, MD, Wei, Ziwen, PhD, Burke, Thomas, PhD, Pietanza, M Catherine, MD, Rodríguez-Abreu, Delvys, MD

Get full text

Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases by Yee, Jasmine, PhD, Davis, Glen M., PhD, Hackett, Daniel, PhD, Beith, Jane M., PhD, FRACP, Wilcken, Nicholas, PhD, FRACP, Currow, David, PhD, FRACP, Emery, Jon, PhD, FRACP, Phillips, Jane, PhD, Martin, Andrew, PhD, Hui, Rina, PhD, FRACP, Harrison, Michelle, FRACP, Segelov, Eva, PhD, FRACP, Kilbreath, Sharon L., PhD

Get full text

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC by Garassino, Marina C., MD, Gadgeel, Shirish, XX, Novello, Silvia, XX, Halmos, Balazs, XX, Felip, Enriqueta, XX, Speranza, Giovanna, XX, Hui, Rina, XX, Garon, Edward B., XX, Horinouchi, Hidehito, XX, Sugawara, Shunichi, XX, Rodriguez-Abreu, Delvys, XX, Reck, Martin, XX, Cristescu, Razvan, XX, Aurora-Garg, Deepti, XX, Loboda, Andrey, XX, Lunceford, Jared, XX, Kobie, Julie, XX, Ayers, Mark, XX, Piperdi, Bilal, XX, Pietanza, M. Catherine, XX, Paz-Ares, Luis, XX

Get full text

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042 by Mansfield, Aaron S., MD, Herbst, Roy S., MD, PhD, de Castro, Gilberto, MD, PhD, Hui, Rina, MB, BS, PhD, Peled, Nir, MD, PhD, Kim, Dong-Wan, MD, Novello, Silvia, MD, PhD, Satouchi, Miyako, MD, Wu, Yi-Long, MD, Garon, Edward B., MD, Reck, Martin, MD, PhD, Robinson, Andrew G., MD, Samkari, Ayman, MD, Piperdi, Bilal, MD, Ebiana, Victoria, MD, Lin, Jianxin, MS, Mok, Tony S.K., MD

Get full text

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC by Vansteenkiste, Johan F., Naidoo, Jarushka, Faivre-Finn, Corinne, Özgüroğlu, Mustafa, Villegas, Augusto, Daniel, Davey, Murakami, Shuji, Hui, Rina, Lee, Ki Hyeong, Cho, Byoung Chul, Kubota, Kaoru, Broadhurst, Helen, Wadsworth, Catherine, Newton, Michael, Thiyagarajah, Piruntha, Antonia, Scott J.

Get full text

Symptomatic Pneumonitis with Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer by Vansteenkiste, Johan F., MD, PhD, Naidoo, Jarushka, MB, BCH, MHS, Faivre–Finn, Corinne, MD, PhD, Özgüroğlu, Mustafa, MD, Villegas, Augusto, MD, Daniel, Davey, MD, Murakami, Shuji, MD, Hui, Rina, MBBS, PhD, Lee, Ki Hyeong, MD, Cho, Byoung Chul, MD, PhD, Kubota, Kaoru, MD, PhD, Broadhurst, Helen, MSc, Wadsworth, Catherine, BVSc, Newton, Michael, PharmD, Thiyagarajah, Piruntha, MD, Antonia, Scott J., MD

Get full text

The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer therapy by Stoodley, Paul W., BSc, Richards, David A.B., MD, FRACP, Meikle, Steve R., PhD, Clarke, Jillian, MSc, Hui, Rina, PhD, FRACP, Thomas, Liza, PhD, FRACP

Get full text

Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study by Hui, Rina, Prof, Özgüroğlu, Mustafa, Prof, Villegas, Augusto, MD, Daniel, Davey, MD, Vicente, David, MD, Murakami, Shuji, MD, Yokoi, Takashi, MD, Chiappori, Alberto, MD, Lee, Ki Hyeong, MD, de Wit, Maike, Prof, Cho, Byoung Chul, Prof, Gray, Jhanelle E, MD, Rydén, Anna, PhD, Viviers, Louis, MD, Poole, Lynne, MSc, Zhang, Yiduo, PhD, Dennis, Phillip A, MD, Antonia, Scott J, MD

Get full text

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an o... by Thatcher, Nick, Prof, Hirsch, Fred R, Prof, Luft, Alexander V, MD, Szczesna, Aleksandra, MD, Ciuleanu, Tudor E, Prof, Dediu, Mircea, MD, Ramlau, Rodryg, Prof, Galiulin, Rinat K, MD, Bálint, Beatrix, MD, Losonczy, György, Prof, Kazarnowicz, Andrzej, MD, Park, Keunchil, MD, Schumann, Christian, Prof, Reck, Martin, MD, Depenbrock, Henrik, MD, Nanda, Shivani, MS, Kruljac-Letunic, Anamarija, PhD, Kurek, Raffael, MD, Paz-Ares, Luis, MD, Socinski, Mark A, Prof

Get full text